200 related articles for article (PubMed ID: 20950304)
1. Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population?
Lee JC; Bénard F; Carrier S; Talwar V; Defoy I
BJU Int; 2011 Mar; 107(6):956-60. PubMed ID: 20950304
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, double-blind, placebo-controlled trial to assess the efficacy of sildenafil citrate in men with unrecognized erectile dysfunction.
Shabsigh R; Kaufman J; Magee M; Creanga D; Russell D; Budhwani M
Urology; 2010 Aug; 76(2):373-9. PubMed ID: 20579708
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk among men seeking help for erectile dysfunction.
Frantzen J; Speel TG; Kiemeney LA; Meuleman EJ
Ann Epidemiol; 2006 Feb; 16(2):85-90. PubMed ID: 16226038
[TBL] [Abstract][Full Text] [Related]
5. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
[TBL] [Abstract][Full Text] [Related]
7. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.
Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE
Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of self-esteem in males with erectile dysfunction treated with viagra. Analysis of a Spanish patients group selected from a multicenter, international study].
Martínez-Jabaloyas JM; Moncada I; Rodríguez-Vela L; Gutiérrez PR; Chaves J
Actas Urol Esp; 2010 Sep; 34(8):699-707. PubMed ID: 20800034
[TBL] [Abstract][Full Text] [Related]
9. Association between comorbidity and erectile dysfunction in patients with diabetes.
Shiri R; Ansari M; Falah Hassani K
Int J Impot Res; 2006; 18(4):348-53. PubMed ID: 16307007
[TBL] [Abstract][Full Text] [Related]
10. [Oral sildenafil demonstrates the effectiveness and well tolerance in the treatment of patients with erectile dysfunction].
Shang XJ; Huang YF
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):877-9. PubMed ID: 16333970
[TBL] [Abstract][Full Text] [Related]
11. Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study.
Turk S; Solak Y; Kan S; Atalay H; Kilinc M; Agca E; Bodur S
Nephrol Dial Transplant; 2010 Nov; 25(11):3729-33. PubMed ID: 20466680
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular safety of PDE5 inhibitors.
Herschorn S
Can J Urol; 2003 Feb; 10 Suppl 1():23-8. PubMed ID: 12625847
[TBL] [Abstract][Full Text] [Related]
13. Assisted semen collection using two phosphodiesterase type 5 inhibitors (Tadalafil and Sildenafil) in infertile men with mild erectile dysfunction.
Tang WH; Liu DF; Jiang H; Ma LL; Hong K; Zhao LM; Mao JM; Yang Y; Zhang J; Gao L; Zhuang XJ; Qiao J
Chin Med J (Engl); 2013 Jul; 126(14):2788-9. PubMed ID: 23876915
[No Abstract] [Full Text] [Related]
14. [Efficacy and safety of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction].
Shen ZJ; Yu YL
Zhonghua Nan Ke Xue; 2005 Aug; 11(8):631-4. PubMed ID: 16138588
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sildenafil on erectile dysfunction in the aged men with diabetes].
He ZJ; Jin J; Zhang K
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):841-2, 846. PubMed ID: 16333965
[TBL] [Abstract][Full Text] [Related]
16. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
17. Summary for patients. Effect of testosterone on response to sildenafil in men with erectile dysfunction.
Ann Intern Med; 2012 Nov; 157(10):I-18. PubMed ID: 23165675
[No Abstract] [Full Text] [Related]
18. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial.
Heiman JR; Talley DR; Bailen JL; Oskin TA; Rosenberg SJ; Pace CR; Creanga DL; Bavendam T
BJOG; 2007 Apr; 114(4):437-47. PubMed ID: 17284249
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction and cardiovascular disease.
Menezes A; Artham S; Lavie CJ; Milani RV; O'Keefe J
Postgrad Med; 2011 May; 123(3):7-16. PubMed ID: 21566411
[TBL] [Abstract][Full Text] [Related]
20. Management of erectile dysfunction.
Heidelbaugh JJ
Am Fam Physician; 2010 Feb; 81(3):305-12. PubMed ID: 20112889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
